Delivery Order SPE2DB20D3103-SPE2DB25FQ4D6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,661.96 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was awarded on September 22, 2025 with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $28,548.57 delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month treatment kits on August 4, 2025, with a completion date of August 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication commonly used in military and federal healthcare systems for...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Lupron Depot 11.25 mg 3-month kits, valued at $4,474.82 with a firm fixed price structure. This competitively awarded delivery order, with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,212.04 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Lupron Depot 3.75 mg kits. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $20,048.58 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $33,612.02. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,043.64 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication used in the treatment of conditions including prostate...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4D6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,611.51 for Lupron Depot 11.25 mg 3-month kits on September 22, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Lupron Depot is a hormone therapy medication commonly used in treating hormone-dependent cancers and certain urological conditions. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly fulfills delivery orders for specialized medications through its DLA prime vendor contract. This award reflects the company's ongoing role in supporting Defense Health Agency medical supply requirements through competitive, firm fixed-price delivery mechanisms that provide flexibility in sourcing pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 9/22/25 |